title: Optimal media for use in air sampling to detect cultivable bacteria and fungi in the pharmacy.
abstract: Current guidelines for air sampling for bacteria and fungi in compounding pharmacies require the use of a medium for each type of organism. U.S. Pharmacopeia (USP) chapter <797> (http://www.pbm.va.gov/linksotherresources/docs/USP797PharmaceuticalCompoundingSterileCompounding.pdf) calls for tryptic soy agar with polysorbate and lecithin (TSApl) for bacteria and malt extract agar (MEA) for fungi. In contrast, the Controlled Environment Testing Association (CETA), the professional organization for individuals who certify hoods and clean rooms, states in its 2012 certification application guide (http://www.cetainternational.org/reference/CAG-009v3.pdf?sid=1267) that a single-plate method is acceptable, implying that it is not always necessary to use an additional medium specifically for fungi. In this study, we reviewed 5.5 years of data from our laboratory to determine the utility of TSApl versus yeast malt extract agar (YMEA) for the isolation of fungi. Our findings, from 2,073 air samples obtained from compounding pharmacies, demonstrated that the YMEA yielded >2.5 times more fungal isolates than TSApl.
authors.affiliation: Microbiology Specialists Incorporated, Houston, Texas, USA.
authors.forename: Alice S
authors.initials: AS
authors.lastname: Weissfeld
authors.forename: Riya Augustin
authors.initials: RA
authors.lastname: Joseph
authors.forename: Theresa V
authors.initials: TV
authors.lastname: Le
authors.forename: Ernest A
authors.initials: EA
authors.lastname: Trevino
authors.forename: M Frances
authors.initials: MF
authors.lastname: Schaeffer
authors.forename: Paula H
authors.initials: PH
authors.lastname: Vance
mesh_terms: D000391:Air Microbiology; D001419:Bacteria / Q000302:isolation & purification*; D003470:Culture Media / Q000737:chemistry*; D005658:Fungi / Q000302:isolation & purification*; D008828:Microbiological Techniques / Q000379:methods*; D010594:Pharmacies; D012680:Sensitivity and Specificity
chemical_list: D003470:Culture Media
references.citation: Pediatrics. 2006 Jul;118(1):e212-5
references.pmid: 16785290
references.citation: MMWR Morb Mortal Wkly Rep. 2012 Oct 19;61(41):839-42
references.pmid: 23076093
references.citation: Clin Infect Dis. 2008 Dec 1;47(11):1372-9
references.pmid: 18937575
references.citation: MMWR Morb Mortal Wkly Rep. 2002 Dec 13;51(49):1109-12
references.pmid: 12530707
references.citation: Clin Infect Dis. 2007 Sep 1;45(5):527-33
references.pmid: 17682984
references.citation: MMWR Morb Mortal Wkly Rep. 2005 Mar 25;54(11):269-72
references.pmid: 15788991
references.citation: MMWR Morb Mortal Wkly Rep. 2012 May 4;61(17):310-1
references.pmid: 22552209
references.citation: Clin Infect Dis. 2006 Oct 1;43(7):831-7
references.pmid: 16941362
references.citation: J Hosp Infect. 2005 Nov;61(3):213-8
references.pmid: 16213372
references.citation: J Clin Microbiol. 2005 Oct;43(10):5316-8
references.pmid: 16208007
references.citation: N Engl J Med. 2013 Oct 24;369(17):1598-609
references.pmid: 23252499
references.citation: J Nucl Med. 2007 Nov;48(11):1911-2; author reply 1912
references.pmid: 17978358
references.citation: Emerg Infect Dis. 2009 Jan;15(1):12-8
references.pmid: 19116043
references.citation: MMWR Morb Mortal Wkly Rep. 1998 Jul 31;47(29):610-2
references.pmid: 9699810
references.citation: N Engl J Med. 2012 Dec 6;367(23):2194-203
references.pmid: 23131029
references.citation: Am J Health Syst Pharm. 2003 Jul 15;60(14):1440-6
references.pmid: 12892028